指南与共识心力衰竭与心肌病心律失常

肥厚型心肌病晚期钆增强评估改善基于当前指南的风险分层

Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines.
指南 / 共识 · Eur Heart J · 2023-01-01

2022年ESC模型预测性能优于2014年ESC模型,LGE可进一步改善基于当前指南的风险分层。

要点

  • 无广泛LGE患者中,LGE≥5%与多变量调整后7倍SCD风险相关。
  • ICD-COR II或III患者中,LGE≥5%且<15%者预后显著差于LGE<5%者。

核心结论

  • 2022年ESC模型预测性能优于2014年ESC模型,尤其敏感性提高。
  • LGE可基于当前指南进一步风险分层。

研究设计与样本

  • 外部验证2022年ESC模型及其他指南ICD推荐类别模型。

主要发现

  • SCD患者ESC Risk-SCD评分更高(4.3±2.4% vs. 2.8±2.1%,P<.001)。
  • SCD患者LGE范围更大(13.7±9.4% vs. 4.9±6.6%,P<.001)。
  • 无广泛LGE患者中,LGE≥5%与多变量调整后7倍SCD风险相关。

临床怎么用

  • 可采用2022年ESC模型评估HCM患者SCD风险以指导ICD一级预防。
  • 对于无广泛LGE的患者,LGE≥5%提示SCD风险增加,可辅助风险分层。
  • 在ICD-COR II或III患者中,LGE≥5%且<15%者预后较差,需加强评估。

局限性

  • 回顾性研究设计。
  • 单中心连续患者样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardioverter defibrillator (ICD) implantation in primary prevention for sudden cardiac death (SCD) is crucial. The aim of this study was to externally validate the 2022 European Society of Cardiology (ESC) model and other guideline-based ICD class of recommendation (ICD-COR) models and explore the utility of late gadolinium enhancement (LGE) in further risk stratification. METHODS: Seven hundred and seventy-four consecutive patients who underwent cardiac magnetic resonance imaging were retrospectively enrolled. RESULTS: Forty-six (5.9%) patients reached the SCD-related endpoint during 7.4 ± 2.5 years of follow-up. Patients suffering from SCD had higher ESC Risk-SCD score (4.3 ± 2.4% vs. 2.8 ± 2.1%, P < .001) and LGE extent (13.7 ± 9.4% vs. 4.9 ± 6.6%, P < .001). Compared with the 2014 ESC model, the 2022 ESC model showed increased area under the curve (.76 vs. .63), sensitivity (76.1% vs. 43.5%), positive predictive value (16.8% vs. 13.6%), and negative predictive value (98.1% vs. 95.9%). The C-statistics for SCD prediction of 2011 American College of Cardiology (ACC)/American Heart Association (AHA), 2014 ESC, 2020 AHA/ACC, and 2022 ESC models were .68, .64, .76 and .78, respectively. Furthermore, in patients without extensive LGE, LGE ≥5% was responsible for seven-fold SCD risk after multivariable adjustment. Whether in ICD-COR II or ICD-COR III, patients with LGE ≥5% and <15% showed significantly worse prognosis than those with LGE <5% (all P < .001). CONCLUSIONS: The 2022 ESC model performed better than the 2014 ESC model with especially improved sensitivity. LGE enabled further risk stratification based on current guidelines.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Wang J, Yang S, Ma X, et al. Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines. Eur Heart J. 2023. PMID: 37795986. doi:10.1093/eurheartj/ehad581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。